| Overview |
| bsm-63069r |
| phospho-Tau (S202) Monoclonal Antibody |
| WB |
| Mouse, Rat |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated Synthesised phosphopeptide derived from human Tau around the phosphorylation site of Ser202 |
| S202 |
| Monoclonal |
| IgG |
| Lot Dependent |
| Purified by Protein A. |
| 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 4137 |
| P10636 |
| Cytoplasm, Cell membrane |
| Tau(Phospho-Ser202); MAPT(phospho 202); phospho-MAPT Tau(pSer202? p-Tau(Ser202); MAPT; Microtuble-associted protein Tau; AI413597; AW045860; DDPAC; Disinhibition dementia parkinsonism amyotrophy complex; FLJ31424; FTDP 17; FTDP17; G Protein beta 1 gamma 2 subunit interacting factor 1; G protein beta1/gamma2 subunit interacting factor 1; MAPTL; MGC134287; MGC138549; MGC156663; Microtubule associated protein tau isoform 4; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; Paired helical filament tau; PHF tau; PHF-tau; PPND; pTau; RNPTAU; Tauopathy and respiratory failure, included; TAU_HUMAN. |
| Application Dilution |
| WB |
1:300-5000 |